Immuno-genomic analysis reveals eosinophilic feature and favorable prognosis of female non-smoking esophageal squamous cell carcinomas.

Eosinophils Esophageal squamous cell carcinoma Mutational signature Non-smoking female Tumor microenvironment

Journal

Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053

Informations de publication

Date de publication:
28 Jan 2024
Historique:
received: 12 09 2023
revised: 13 11 2023
accepted: 16 11 2023
pubmed: 28 11 2023
medline: 28 11 2023
entrez: 28 11 2023
Statut: ppublish

Résumé

Most of esophageal squamous cell carcinoma (ESCC) develop in smoking males in Japan, but the genomic etiology and immunological characteristics of rare non-smoking female ECSS remain unclear. To elucidate the genomic and immunological features of ESCC in non-smoking females, we analyzed whole-genome or transcriptome sequencing data from 94 ESCCs, including 20 rare non-smoking female cases. In addition, 31,611 immune cells were extracted from four ESCC tissues and subject to single-cell RNA-seq. We compared their immuno-genomic and microbiome profiles between non-smoking female and smoking ESCCs. Non-smoking females showed much better prognosis. Whole-genome sequencing analysis showed no significant differences in driver genes or copy number alterations depending on smoking status. The mutational signatures specifically observed in non-smoking females ESCC could be attributed to aging. Immune profiling from RNA-seq revealed that ESCC in non-smoking females had high tumor microenvironment signatures and a high abundance of eosinophils with a favorable prognosis. Single-cell RNA-sequencing of intratumor immune cells revealed gender differences of eosinophils and their activation in female cases. ESCCs in non-smoking females have age-related mutational signatures and gender-specific tumor immune environment with eosinophils, which is likely to contribute to their favorable prognosis.

Identifiants

pubmed: 38013050
pii: S0304-3835(23)00450-0
doi: 10.1016/j.canlet.2023.216499
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

216499

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yuki Okawa (Y)

Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo, Japan.

Shota Sasagawa (S)

Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Hiroaki Kato (H)

Department of Surgery, Graduate School of Medicine, Kindai University, Osaka, Japan.

Todd A Johnson (TA)

Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Koji Nagaoka (K)

Department of Immunotherapeutics, The University of Tokyo Hospital, Tokyo, Japan.

Yukari Kobayashi (Y)

Department of Immunotherapeutics, The University of Tokyo Hospital, Tokyo, Japan.

Akimasa Hayashi (A)

Department of Pathology, Kyorin University Faculty of Medicine, Mitaka, Japan.

Takahiro Shibayama (T)

Department of Pathology, Kyorin University Faculty of Medicine, Mitaka, Japan.

Kazuhiro Maejima (K)

Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Hiroko Tanaka (H)

M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.

Satoru Miyano (S)

M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.

Junji Shibahara (J)

Department of Pathology, Kyorin University Faculty of Medicine, Mitaka, Japan.

Satoshi Nishizuka (S)

Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Japan.

Satoshi Hirano (S)

Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo, Japan.

Yasuyuki Seto (Y)

Department of GI Surgery, Graduate of School of Medicine, The University of Tokyo, Tokyo, Japan.

Takeshi Iwaya (T)

Department of Clinical Oncology, Iwate Medical University School of Medicine, Yahaba, Japan.

Kazuhiro Kakimi (K)

Department of Immunotherapeutics, The University of Tokyo Hospital, Tokyo, Japan; Department of Immunology, Graduate School of Medicine, Kindai University, Osaka, Japan.

Takushi Yasuda (T)

Department of Surgery, Graduate School of Medicine, Kindai University, Osaka, Japan.

Hidewaki Nakagawa (H)

Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. Electronic address: hidewaki@riken.jp.

Classifications MeSH